Business Standard

Delisting candidates rally as Sebi sticks to shareholding norms deadline

Fresenius Kabi Oncology, Astrazeneca Pharma India, BOC India & Honeywell Automation rise more than 5% each

Related News

Shares of the multinational companies (MNCs), which would be probable candidates, are in limelight on the bourses on reports that the market regulator Sebi said that it will not extend the deadline to comply with minimum public shareholding norms.

Fresenius Kabi Oncology, Astrazeneca Pharma India, BOC India, Honeywell Automation India, Sharp India, Wendt India, Kennametal India and Elantas Beck India, having promoter holding more than 75% each, have rallied more than 5% each on the Bombay Stock Exchange (BSE) at 1121 hours.

In 2010, SEBI had come out with norms that government firms should have a minimum public shareholding of 10% while for private companies it is 25%. These guidelines were to be complied within three years.

While the private companies have to meet norms by June 2013, for public sector undertakings (PSUs) the deadline is August 2013.

According to analyst at ICICI Securities, the corporates, particularly fundamentally strong may not have the inclination to increase their public holding and may resort to delisting to have better flexibility in taking business decisions.

The case for delisting becomes stronger in the current weak trend prevailing in the equity markets, which has led to a substantial fall in stock prices providing an opportunity for such corporates to buy out the remaining stake with the public at lower valuations, he added.

Read more on:   
|
|

Read More

Sebi imposes fine on three persons for lack of disclosure

Pursuant to this purchase, their total holding rose to 11.2% in the company, crossing a threshold limit of 10% to attract the provisions of Sebi's ...

Quick Links

 

Market News

Maruti Suzuki India, Axis Bank joins Rs 1-lakh-cr market-cap club

Axis Bank hits a record high of Rs 440, while Maruti Suzuki touched a new high of Rs 3,349 in intra-day deals on BSE.

Marksans Pharma surges on strong Q2 results

The stock rallied 6% to Rs 64 on NSE after reporting 56% yoy growth in net profit at Rs 31 crore in September quarter.

Markets continue winning streak; Sensex up 400 points

The 30-share Sensex is up 412 points at 27,758 and the 50-share Nifty has gained 119 points to trade at 8,288.

Copper down 0.2% on weak global cues

Metal for delivery in November shed 0.14%

Silver down 0.6% on weak global trend

Weak trend trend overseas, eroding demand for the precious metals, pulled down silver prices

Back to Top